OR13-2 Characterizing the Impact of Burosumab on Bone Health in Children with X-Linked Hypophosphatemia: Results from Year 1 of the Disease Monitoring Program

por Carpenter, Thomas, Cassinelli, Hamilton, Glorieux, Francis, Hetzer, Joel, Merritt II, J Lawrence, Moreira, Carolina A, Portale, Anthony, Ward, Leanne, Woo, Claudine, Imel, Erik
Publicado 2022

OR13-1 Long-Term Burosumab Therapy Provides Sustained Benefit in Patients with Tumor-Induced Osteomalacia: End of Study Findings From the Pivotal Phase 2 Study

por Carpenter, Thomas, Cimms, Tricia, Hetzer, Joel, Insogna, Karl, Kumar, Rajiv, Merritt II, J Lawrence, Miller, Paul, Peacock, Munro, Rauch, Frank, Stanciu, Irinel, Weber, Thomas, Jan De Beur, Suzanne
Publicado 2022